The biopsy devices market size has grown strongly in recent years. It will grow from $3.24 billion in 2025 to $3.53 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to rising cancer screening rates, expansion of diagnostic imaging centers, increased use of biopsy procedures for early diagnosis, availability of advanced imaging modalities, growth in hospital diagnostic capabilities.
The biopsy devices market size is expected to see strong growth in the next few years. It will grow to $4.95 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing adoption of AI-assisted biopsy guidance, rising demand for outpatient diagnostic procedures, expansion of precision oncology practices, growing focus on early disease detection, increasing investments in advanced biopsy technologies. Major trends in the forecast period include increasing adoption of image-guided biopsy systems, rising use of minimally invasive biopsy techniques, growing demand for precision sampling devices, expansion of automated biopsy guidance technologies, enhanced focus on diagnostic accuracy.
An increasing number of surgeries is anticipated to drive the growth of the biopsy devices market. Surgery is a medical field dedicated to treating injuries, illnesses, and various disorders through manual and instrumental techniques. Biopsy devices are commonly used in surgical procedures to extract small tissue samples or clusters of cells for further laboratory examination. For example, in July 2025, according to the American Med Spa Association, a US-based provider of legal, compliance, and business resources for medical spas and medical aesthetic practices, cosmetic procedure volumes have risen by 42.5% over the past four years, reaching 20.5 million non-surgical treatments and 17.4 million surgical procedures in 2024. Consequently, the increasing number of surgeries is fueling the growth of the biopsy devices market moving forward.
Major companies operating in the biopsy devices market are concentrating on the development of advanced solutions such as fine-needle biopsy precision technology to improve diagnostic accuracy and sample integrity. Fine-needle biopsy precision technology involves the engineering of needles with specialized tip designs and robust materials that enhance tissue acquisition while maintaining cellular structure, enabling dependable pathological evaluation. For example, in October 2025, Olympus, a Japan-based medical technology company, introduced the SecureFlex single-use fine-needle biopsy device, which incorporates nitinol construction and a dual-beveled Raptor Tip. This tip facilitates the retrieval of larger, intact tissue samples by reducing tissue loss and enhancing penetration performance. The device also features a multi-layer sheath that allows stable access to complex anatomical regions, including the pancreatic head and uncinate process, without repeated scope repositioning. SecureFlex enables fine-needle biopsy through EUS-FNB for gastrointestinal lesions and supports the collection of high-quality tissue for accurate diagnosis and treatment planning. Overall, the device improves sample quality, procedural efficiency, and safety in endoscopic biopsy procedures.
In June 2023, Quest Diagnostics, a US-based medical laboratories company, successfully acquired Haystack Oncology for an undisclosed amount. This strategic move aims to integrate Haystack Oncology's highly sensitive minimal-residual disease (MRD) testing technology, which is based on circulating tumor DNA (ctDNA). Quest Diagnostics plans to leverage this technology in the development of innovative blood-based clinical laboratory services for solid tumor cancers, with availability expected to commence in 2024.
Major companies operating in the biopsy devices market are Becton Dickinson and Company, Hologic Inc, Boston Scientific Corporation, Cook Medical LLC, Argon Medical Devices Inc, Olympus Corporation, Medtronic plc, Stryker Corporation, B Braun Melsungen AG, INRAD Inc, TSK Laboratory, Mauna Kea Technologies, Veran Medical Technologies, Merit Medical Systems Inc, ConMed Corporation, DTR Medical, Gallini Srl, TransMed7 LLC, MDL Srl, Biopsybell Srl.
North America was the largest region in the biopsy devices market in 2025. Asia-Pacific was the second largest region in the global biopsy devices market report share. The regions covered in the biopsy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biopsy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the biopsy devices market by increasing costs of imported needles, imaging components, guidance systems, precision instruments, and electronic subsystems. Diagnostic centers and hospitals in North America and Europe are most affected due to reliance on imported biopsy technologies, while Asia-Pacific faces increased manufacturing costs for export markets. These tariffs are raising device prices and extending procurement timelines. However, they are also supporting localized production, regional supplier partnerships, and development of cost-effective biopsy solutions.
The biopsy devices market research report is one of a series of new reports that provides biopsy devices market statistics, including biopsy devices industry global market size, regional shares, competitors with a biopsy devices market share, detailed biopsy devices market segments, market trends and opportunities, and any further data you may need to thrive in the biopsy devices industry. This biopsy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Biopsy devices are utilized to obtain sample cells or tissues from a patient’s body for examination to ascertain the presence of a disease. They play a crucial role in diagnosing diseases, particularly cancer, by allowing healthcare professionals to analyze cellular structures and detect abnormal or cancerous cells.
Key product types within biopsy devices include needle-based biopsy instruments, core biopsy devices, aspiration biopsy needles, vacuum-assisted biopsy devices, biopsy forceps, and localization wires. Core biopsy devices utilize a large hollow needle to make a small incision in the skin over the lump. Imaging technologies associated with these devices include MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy, and CT scan. Applications span breast biopsy, gynecological biopsy, prostate biopsy, liver biopsy, lung biopsy, kidney biopsy, gastroenterology biopsy, and others, with usage in diagnostics and imaging centers, hospitals, and similar medical settings.
The biopsy devices market consists of sales of core biopsy guns, core biopsy needles, aspiration biopsy needles, vacuum-assisted biopsy systems, vacuum-assisted biopsy needles, localization wires, procedure trays, and other biopsy devices that are used to diagnose various diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The biopsy devices market size is expected to see strong growth in the next few years. It will grow to $4.95 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing adoption of AI-assisted biopsy guidance, rising demand for outpatient diagnostic procedures, expansion of precision oncology practices, growing focus on early disease detection, increasing investments in advanced biopsy technologies. Major trends in the forecast period include increasing adoption of image-guided biopsy systems, rising use of minimally invasive biopsy techniques, growing demand for precision sampling devices, expansion of automated biopsy guidance technologies, enhanced focus on diagnostic accuracy.
An increasing number of surgeries is anticipated to drive the growth of the biopsy devices market. Surgery is a medical field dedicated to treating injuries, illnesses, and various disorders through manual and instrumental techniques. Biopsy devices are commonly used in surgical procedures to extract small tissue samples or clusters of cells for further laboratory examination. For example, in July 2025, according to the American Med Spa Association, a US-based provider of legal, compliance, and business resources for medical spas and medical aesthetic practices, cosmetic procedure volumes have risen by 42.5% over the past four years, reaching 20.5 million non-surgical treatments and 17.4 million surgical procedures in 2024. Consequently, the increasing number of surgeries is fueling the growth of the biopsy devices market moving forward.
Major companies operating in the biopsy devices market are concentrating on the development of advanced solutions such as fine-needle biopsy precision technology to improve diagnostic accuracy and sample integrity. Fine-needle biopsy precision technology involves the engineering of needles with specialized tip designs and robust materials that enhance tissue acquisition while maintaining cellular structure, enabling dependable pathological evaluation. For example, in October 2025, Olympus, a Japan-based medical technology company, introduced the SecureFlex single-use fine-needle biopsy device, which incorporates nitinol construction and a dual-beveled Raptor Tip. This tip facilitates the retrieval of larger, intact tissue samples by reducing tissue loss and enhancing penetration performance. The device also features a multi-layer sheath that allows stable access to complex anatomical regions, including the pancreatic head and uncinate process, without repeated scope repositioning. SecureFlex enables fine-needle biopsy through EUS-FNB for gastrointestinal lesions and supports the collection of high-quality tissue for accurate diagnosis and treatment planning. Overall, the device improves sample quality, procedural efficiency, and safety in endoscopic biopsy procedures.
In June 2023, Quest Diagnostics, a US-based medical laboratories company, successfully acquired Haystack Oncology for an undisclosed amount. This strategic move aims to integrate Haystack Oncology's highly sensitive minimal-residual disease (MRD) testing technology, which is based on circulating tumor DNA (ctDNA). Quest Diagnostics plans to leverage this technology in the development of innovative blood-based clinical laboratory services for solid tumor cancers, with availability expected to commence in 2024.
Major companies operating in the biopsy devices market are Becton Dickinson and Company, Hologic Inc, Boston Scientific Corporation, Cook Medical LLC, Argon Medical Devices Inc, Olympus Corporation, Medtronic plc, Stryker Corporation, B Braun Melsungen AG, INRAD Inc, TSK Laboratory, Mauna Kea Technologies, Veran Medical Technologies, Merit Medical Systems Inc, ConMed Corporation, DTR Medical, Gallini Srl, TransMed7 LLC, MDL Srl, Biopsybell Srl.
North America was the largest region in the biopsy devices market in 2025. Asia-Pacific was the second largest region in the global biopsy devices market report share. The regions covered in the biopsy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biopsy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the biopsy devices market by increasing costs of imported needles, imaging components, guidance systems, precision instruments, and electronic subsystems. Diagnostic centers and hospitals in North America and Europe are most affected due to reliance on imported biopsy technologies, while Asia-Pacific faces increased manufacturing costs for export markets. These tariffs are raising device prices and extending procurement timelines. However, they are also supporting localized production, regional supplier partnerships, and development of cost-effective biopsy solutions.
The biopsy devices market research report is one of a series of new reports that provides biopsy devices market statistics, including biopsy devices industry global market size, regional shares, competitors with a biopsy devices market share, detailed biopsy devices market segments, market trends and opportunities, and any further data you may need to thrive in the biopsy devices industry. This biopsy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Biopsy devices are utilized to obtain sample cells or tissues from a patient’s body for examination to ascertain the presence of a disease. They play a crucial role in diagnosing diseases, particularly cancer, by allowing healthcare professionals to analyze cellular structures and detect abnormal or cancerous cells.
Key product types within biopsy devices include needle-based biopsy instruments, core biopsy devices, aspiration biopsy needles, vacuum-assisted biopsy devices, biopsy forceps, and localization wires. Core biopsy devices utilize a large hollow needle to make a small incision in the skin over the lump. Imaging technologies associated with these devices include MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy, and CT scan. Applications span breast biopsy, gynecological biopsy, prostate biopsy, liver biopsy, lung biopsy, kidney biopsy, gastroenterology biopsy, and others, with usage in diagnostics and imaging centers, hospitals, and similar medical settings.
The biopsy devices market consists of sales of core biopsy guns, core biopsy needles, aspiration biopsy needles, vacuum-assisted biopsy systems, vacuum-assisted biopsy needles, localization wires, procedure trays, and other biopsy devices that are used to diagnose various diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Biopsy Devices Market Characteristics
3. Biopsy Devices Market Supply Chain Analysis
4. Global Biopsy Devices Market Trends and Strategies
5. Biopsy Devices Market Analysis of End Use Industries
7. Global Biopsy Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Biopsy Devices Total Addressable Market (TAM) Analysis for the Market
9. Biopsy Devices Market Segmentation
10. Biopsy Devices Market Regional and Country Analysis
11. Asia-Pacific Biopsy Devices Market
12. China Biopsy Devices Market
13. India Biopsy Devices Market
14. Japan Biopsy Devices Market
15. Australia Biopsy Devices Market
16. Indonesia Biopsy Devices Market
17. South Korea Biopsy Devices Market
18. Taiwan Biopsy Devices Market
19. South East Asia Biopsy Devices Market
20. Western Europe Biopsy Devices Market
21. UK Biopsy Devices Market
22. Germany Biopsy Devices Market
23. France Biopsy Devices Market
24. Italy Biopsy Devices Market
25. Spain Biopsy Devices Market
26. Eastern Europe Biopsy Devices Market
27. Russia Biopsy Devices Market
28. North America Biopsy Devices Market
29. USA Biopsy Devices Market
30. Canada Biopsy Devices Market
31. South America Biopsy Devices Market
32. Brazil Biopsy Devices Market
33. Middle East Biopsy Devices Market
34. Africa Biopsy Devices Market
36. Biopsy Devices Market Competitive Landscape and Company Profiles
37. Biopsy Devices Market Other Major and Innovative Companies
40. Biopsy Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Biopsy Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses biopsy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for biopsy devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biopsy devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Needle-Based Biopsy Guns; Biopsy Forceps; Biopsy Guidance Systems; Biopsy Needles; Other Products2) By Image Guiding Technology: MRI-Guided Biopsy; Stereotactic-Guided Biopsy; Ultrasound-Guided Biopsy; Other Imaging Technologies
3) By Application: Breast Biopsy; Gynecological Biopsy; Prostate Biopsy; Blood Cancers Biopsy; Skin Biopsy; Kidney Biopsy; Gastroenterology Biopsy; Other Applications
4) By End User: Diagnostics And Imaging Centers; Hospitals; Other End User
Subsegments:
1) By Needle-Based Biopsy Guns: Spring-Loaded Biopsy Guns; Vacuum-Assisted Biopsy Guns2) By Biopsy Forceps: Endoscopic Biopsy Forceps; Surgical Biopsy Forceps
3) By Biopsy Guidance Systems: Ultrasound-Guided Biopsy Systems; CT-Guided Biopsy Systems; MRI-Guided Biopsy Systems
4) By Biopsy Needles: Core Needles; Fine Needle Aspiration (FNA) Needles; Coaxial Needles
5) By Other Products: Biopsy Sutures; Biopsy Markers; Biopsy Storage Solutions
Companies Mentioned: Becton Dickinson and Company; Hologic Inc; Boston Scientific Corporation; Cook Medical LLC; Argon Medical Devices Inc; Olympus Corporation; Medtronic plc; Stryker Corporation; B Braun Melsungen AG; INRAD Inc; TSK Laboratory; Mauna Kea Technologies; Veran Medical Technologies; Merit Medical Systems Inc; ConMed Corporation; DTR Medical; Gallini Srl; TransMed7 LLC; MDL Srl; Biopsybell Srl
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Biopsy Devices market report include:- Becton Dickinson and Company
- Hologic Inc
- Boston Scientific Corporation
- Cook Medical LLC
- Argon Medical Devices Inc
- Olympus Corporation
- Medtronic plc
- Stryker Corporation
- B Braun Melsungen AG
- INRAD Inc
- TSK Laboratory
- Mauna Kea Technologies
- Veran Medical Technologies
- Merit Medical Systems Inc
- ConMed Corporation
- DTR Medical
- Gallini Srl
- TransMed7 LLC
- MDL Srl
- Biopsybell Srl
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.53 Billion |
| Forecasted Market Value ( USD | $ 4.95 Billion |
| Compound Annual Growth Rate | 8.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
